Getting Groundbreaking Medical Technology Out of the Lab
New medical technologies hold immense promise for treating a range of conditions. Despite the pace of innovation in the medtech field, however, most discoveries never make it out of the laboratory. New research from EPFL could fast-track the route to clinical translation.
Gold Nanoparticles Uncover Structural Diversity of Amyloid Fibrils
EPFL scientists have developed powerful tools to unmask the structural diversity of amyloid fibrils, which are associated with Alzheimer’s disease and other neurodegenerative disorders. The scientists made the breakthrough by developing gold nanoparticles that combine with cryogenic transmission electron microscopy, to provide rapid and unprecedented images of fibrils.
Seminars and Events
not to be missed!
you might be interested in…
Learn about the Institute’s mission and research portfolio
Discover Bachelor, Master and Ph.D., or relevant Summer Research Programs
Granted annually to an exceptional young bioengineer showing potential to embody the next generation of leading scientists in this field